SEC Filing Details
Document Details
Form
Filing Date
May 4, 2023
Document Date
03/31/23
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Protalix BioTherapeutics
Issuer
PROTALIX BIOTHERAPEUTICS, INC.